Patents/Inventors

Shahrooz Rabizadeh

Culver City, CAUS31 patents

28 Patents

US125656822026
Methods of Treating Cancer
Nantcell, Inc.
0 cites
US124912012025
Maximizing T-cell Memory and Compositions and Methods Therefor
Nantcell, Inc.
0 cites
US124166352025
Live Cell Imaging Systems and Methods to Validate Triggering of Immune Response
Nant Holdings IP, LLC
0 cites
US124126392025
Method of Characterizing a Tumor Based on an Immune Gene Expression Signature in Regulatory T Cell (treg)-enriched Tumor Samples
Nant Holdings IP, LLC
0 cites
US124063662025
Real-time Whole Slide Pathology Image Cell Counting
Nantomics, LLC
0 cites
US123547092025
Systems, Methods, and Compositions for Viral-associated Tumors
Five3 Genomics, LLC
0 cites
US122905582025
Sars-cov-2 Vaccines Comprising Human Adenovirus Vectors Encoding Spike and Nucleocapsid-etsd Immunogens
Immunitybio, Inc.
0 cites
US122240662025
Deep Learning Models for Region of Interest Determination
Nantcell, Inc.
0 cites
US122050332025
Weakly Supervised Learning with Whole Slide Images
Nanthealth, Inc.
0 cites
US121958082025
Dynamic Changes in Circulating Free RNA of Neural Tumors
Nantomics LLC
0 cites
US120723372024
Circulating Tumor Cell Enrichment Using Neoepitopes
Nant Holdings IP, LLC
0 cites
US120535122024
Method of Validating the Triggering of an Immune Response to a Neoepitope of a Tumor with T-cells
Nantomics, LLC
0 cites
US119818932024
DNA Stabilization of RNA
Nantomics LLC
0 cites
US119545962024
Weakly Supervised Learning with Whole Slide Images
Nanthealth, Inc.
0 cites
US119548562024
Real-time Whole Slide Pathology Image Cell Counting
Nantomics, LLC
0 cites
US119486872024
Deep Learning Models for Region-of-interest Determination
Nantomics, LLC
0 cites
US118758772024
Immunotherapy Markers and Uses Therefor
Nantomics, LLC
0 cites
US118576202024
Method of Inducing Immunity Against Sars-cov-2 Using Spike (s) and Nucleocapsid (N)-ETSD Immunogens Delivered by a Replication-defective Adenovirus
Immunitybio, Inc.
0 cites
US118210432023
Dynamic Changes in Circulating Free RNA of Neural Tumors
Nantomics LLC
0 cites
US118106722023
Cancer Score for Assessment and Response Prediction from Biological Fluids
Nantomics, LLC
0 cites
US117566512023
Method of Treating a Tumor in a Patient Based on an Immune Gene Expression
Nant Holdings IP, LLC
0 cites
US117251862023
Recombinant NK Cells Expressing Co-stimulatory Molecules
Nant Holdings IP, LLC
0 cites
US117027032023
Targeted Cell Free Nucleic Acid Analysis
Nanthealth Labs, Inc.
0 cites
US116230012023
Compositions and Methods for Viral Cancer Neoepitopes
Nantomics, LLC
0 cites
US116261872023
Systems, Compositions, and Methods for Discovery of MSI and Neoepitopes That Predict Sensitivity to Checkpoint Inhibitors
Nantomics LLC
0 cites
US115902172023
Neoepitope Vaccine and Immune Stimulant Combinations and Methods
Nantcell, Inc.
0 cites
US115858052023
Methods of Immunogenic Modulation
Nant Holdings IP, LLC
0 cites
US115649802023
Tumor Treatment Method with an Individualized Peptide Vaccine
Nantcell, Inc.
0 cites